Status: Not yet recruiting
Phase Ib/II Trial of Cladribine/Ruxolitinib/Venetoclax in Patients With Relapsed/Refractory T-cell Prolymphocytic Leukemia
The goal of this clinical research study is to learn if the combination of ruxolitinib with cladribine and venetoclax can help to control the disease in patients with R/R T-PLL.
Participants needed: 36
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: M.D. Anderson Cancer CenterUpdated: Dec 31, 2025Locations: 1
Eligibility criteria
Patients must have histologically confirmed a diagnosis T-PLL that is relapsed o... [+18]
Pregnant women are excluded from this study because the agent used has the poten... [+9]